Pregled bibliografske jedinice broj: 619986
GENETIC BACKGROUND OF TESTICULAR GERM CELL TUMORS: MODERN INSIGHT AND STANDARD TREATMENT
GENETIC BACKGROUND OF TESTICULAR GERM CELL TUMORS: MODERN INSIGHT AND STANDARD TREATMENT // Symposia Abstract 24th FAPA Congress 2012
Bali, Indonezija, 2012. (predavanje, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 619986 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
GENETIC BACKGROUND OF TESTICULAR GERM CELL TUMORS: MODERN INSIGHT AND STANDARD TREATMENT
Autori
Vladušić, Tomislav ; Hrašćan, Reno ; Pećina-Šlaus, Nives ; Krušlin, Božo ; Vrhovac, Ivana ; Garaj-Vrhovac, Verica ; Franekić, Jasna
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Symposia Abstract 24th FAPA Congress 2012
/ - , 2012
Skup
24th FAPA Congress 2012
Mjesto i datum
Bali, Indonezija, 13.09.2012. - 16.09.2012
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
testicular germ cell tumors; seminoma; nonseminoma; loss of heterozygosity; microsatellite instability
Sažetak
Human testicular germ cell tumors (TGCTs) are histologically heterogenous neoplasms with variable malignant potential. Two main groups, seminomas and nonseminomas, differ biologically and clinically. Although found together in a patient, their development and evolution of clinical response is not fully understood. Despite high curability, cases of chemoresistance arise. To gain insight about the role of genetic background in development and clinical outcome of TGCTs, tissue samples were analysed for loss of heterozygosity (LOH) and microsatellite instability (MSI) within a set of genes involved in cell adhesion (CDH1, APC, NME1), cell cycle regulation(CDKN2A, RB1, TP53), DNA damage repair (BRCA1, MLH1, MSH2, RAD51), apoptosis regulation (BAX) and multidrug resistance (ABCG2). Different pattern of LOH has been observed between the two TGCTs groups and no common structural genetic alteration was found, suggesting of independent development for TGCT groups. LOHs of several genes with synergistic effect (CDH1, CDKN2A, RB1, TP53), as well as higher incidence of LOH in TGCTs harboring highly metastatic and chemoresistant histological components, may provide a clue to their clinical behavior. The analysis of genes involved in DNA damage repair showed no changes in agreement with the fact MSI has not been observed, and most of TGCTs respond well to therapy. Genetic background of these tumors may help to develop better patient management strategies in regard to usual invasive therapy regimes.
Izvorni jezik
Engleski
Znanstvena područja
Biotehnologija
POVEZANOST RADA
Projekti:
058-0582261-2246 - Utjecaj mutagena i antimutagena na molekularne procese u stanici (Hrašćan, Reno, MZOS ) ( CroRIS)
Ustanove:
Prehrambeno-biotehnološki fakultet, Zagreb
Profili:
Božo Krušlin
(autor)
Reno Hrašćan
(autor)
Tomislav Vladušić
(autor)
Ivana Vrhovac Madunić
(autor)
Nives Pećina-Šlaus
(autor)
Jasna Franekić
(autor)